Home › Funds › Prudential Financial › AMLX
Prudential Financial position in AMLX
AMYLYX PHARMACEUTICALS INC · Health Care
Latest position (Q2 2026)15.11K sh
Reported value held$271.38K
Portfolio Weight0.00%
First reportedQ3 2024
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 19.40K | $62.86K | New |
| Q4 2024 | 19.40K | $73.33K | Hold |
| Q1 2025 | 15.20K | $53.81K | Reduce |
| Q2 2025 | 15.62K | $100.12K | Add |
| Q3 2025 | 10.15K | $138.01K | Reduce |
| Q1 2026 | 14.12K | $196.27K | New |
| Q2 2026 | 15.11K | $271.38K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding AMLX
- Fidelity Management & Research (FMR) 16.73M sh · $300.43M · Q2 2026
- BlackRock Inc 8.83M sh · $158.53M · Q2 2026
- Vanguard Group 5.80M sh · $70.12M · Q4 2025
- Janus Henderson Group 4.99M sh · $69.26M · Q1 2026
- Morgan Stanley 3.13M sh · $56.23M · Q2 2026
- Franklin Resources 2.95M sh · $52.99M · Q2 2026
- Goldman Sachs Group 2.86M sh · $51.33M · Q2 2026
- Geode Capital Management 2.34M sh · $41.95M · Q2 2026
- JPMorgan Chase & Co 1.86M sh · $34.92M · Q2 2026
- Northern Trust Corp 831.74K sh · $14.94M · Q2 2026
- Bank of America Corp 821.84K sh · $14.76M · Q2 2026
- Charles Schwab Investment Management 725.03K sh · $13.02M · Q2 2026